home / stock / vtrs / vtrs news


VTRS News and Press, Viatris Inc. From 05/30/24

Stock Information

Company Name: Viatris Inc.
Stock Symbol: VTRS
Market: NASDAQ
Website: viatris.com

Menu

VTRS VTRS Quote VTRS Short VTRS News VTRS Articles VTRS Message Board
Get VTRS Alerts

News, Short Squeeze, Breakout and More Instantly...

VTRS - Viatris: Skeptics Proven Right Once Again

2024-05-30 18:16:29 ET Summary Viatris Inc. reported Q1 2024 results in line with expectations, with a 2% decline in net sales. The company's EBITDA and free cash flow have been negatively impacted by declining sales, and its debt to EBITDA ratio remains high. Despite the low ...

VTRS - LUV, SQ, IAU, VTRS, GLD showing five-day downward plunge

2024-05-27 10:47:04 ET Southwest Airlines Co (LUV) LUV is trading DOWN for the last 4 days, and it at trading at $27.02 with volume of 6,830,596 and a one day change of $-0.40 (-1.46%). Southwest Airlines Co has a 52-week low of 21.91 and a 52-week high of $39.53. The business's 50-...

VTRS - Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale

Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale PR Newswire Company continues to supply high-quality medicines to approximately 1 billion patients annually Report chronicles Viatris' commitment to providing access to healthcare an...

VTRS - SOUN, LI, RDFN, VTRS, BENF showing five-day downward plunge

2024-05-17 10:47:03 ET SoundHound AI Inc. (SOUN) SOUN is trading DOWN for the last 4 days, and it at trading at $5.08 with volume of 17,289,089 and a one day change of $-0.13 (-2.50%). SoundHound AI Inc. has a 52-week low of 1.00 and a 52-week high of $5.11. The business's 50-day mo...

VTRS - Regeneron wins temporary restraining order preventing Eylea generics

2024-05-17 10:01:34 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals Inc (REGN) RBC Capital Markets Global Healthcare Conference (Transcript) Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks Regeneron Pharmaceuticals, Inc. (REGN) ...

VTRS - Larry Robbins' Glenview Capital takes in Broadcom, exits Intel among Q1 moves

2024-05-16 11:01:24 ET Billionaire Larry Robbins' Glenview Capital Management took a stake in Broadcom ( NASDAQ: AVGO ), exited its position in Intel ( NASDAQ: INTC ), and substantially added to holdings in health insurers in Q1 2024, among other changes.... Read the f...

VTRS - Viatris Inc. (VTRS) BofA Securities 2024 Health Care Conference (Transcript)

2024-05-14 19:18:07 ET Viatris Inc. (VTRS) BofA Securities 2024 Health Care Conference May 14, 2024, 01:00 PM ET Company Participants Doretta Mistras - Chief Financial Officer Philippe Martin - Chief R&D Officer Conference Call Participants Jason Gerb...

VTRS - Tracking Christopher Davis' Davis Selected Advisers 13F Portfolio - Q1 2024 Update

2024-05-13 22:19:41 ET Summary Davis Selected Advisers' 13F portfolio value increased to $17.84B, with a decrease in the number of holdings from 103 to 98. The top three holdings in the portfolio are Berkshire Hathaway, Meta Platforms, and Capital One Financial. Stake increase...

VTRS - 8 out of 12 S&P 500 healthcare companies beat profit consensus this week: Earnings Scorecard

2024-05-12 11:22:00 ET This week, the healthcare sector saw 12 companies reporting their quarterly earnings, with 8 of them beating their bottom-line numbers for the quarter.... Read the full article on Seeking Alpha For further details see: 8 out of 12 S&P 500 healthcar...

VTRS - Organon Graduates From Spinoff Skepticism, With A Yield Above 5%

2024-05-11 06:58:33 ET Summary Organon, Pfizer, and Bristol Myers all offer yields above 5% and can  compete with most Treasuries, but only Organon is up YTD. Spinoffs often struggle in their initial years, but Organon's partial reversal of its decline since Merck's castoff h...

Previous 10 Next 10